REGN vs WSM · P/E 14, rev $4.29B vs P/E 25, rev $3.77B
Regeneron Pharmaceuticals Inc (REGN) versus Williams-Sonoma Inc (WSM) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Williams-Sonoma Inc (WSM) is a specialty retail company listed on NYSE.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported WSM revenue for 2026-08-02 was $3.77B. Net income was $569.5M. WSM currently screens at market cap $26.04B and trailing P/E 24.8.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. WSM currently screens at market cap $26.04B and trailing P/E 24.8.
Not investment advice. Open the REGN and WSM stock pages for the full models.
Not investment advice.